license: cc-by-4.0
pretty_name: FKBP12 F36V Binder Designs (PDB 1BL4)
task_categories:
- tabular-regression
- graph-ml
- other
size_categories:
- n<1K
configs:
- config_name: default
data_files:
- split: train
path: designs.csv
language:
- en
tags:
- chemistry
- biology
- drug-discovery
- FKBP12
- FKBP1A
- FKBP
- F36V
- FKBP12-F36V
- P62942
- immunophilin
- PPIase
- peptidyl-prolyl-isomerase
- bump-hole
- bumped-ligand
- chemical-biology
- chemically-induced-proximity
- induced-proximity
- dTAG
- degron
- degradation-tag
- AP1497
- SLF
- synthetic-ligand-of-FKBP
- rapamycin
- FK506
- tacrolimus
- chemical-inducer-of-dimerization
- CID
- molecular-glue
- bifunctional
- heterobifunctional
- PROTAC
- RIPTAC
- targeted-protein-degradation
- protein-protein-interaction
- ternary-complex
- 1BL4
- molecular-docking
- autodock-vina
- protein-ligand-complex
- structure-based-drug-design
- de-novo-design
- generative-design
- generative-ai
- ai-generated
- genetic-algorithm
- GA-II
- synthetic-data
- small-molecule
- SMILES
- SDF
- cheminformatics
- computational-chemistry
- virtual-screening
- TC-43
- technetium
FKBP12 F36V Binder Designs (PDB 1BL4)
165 de novo, generative-AI–designed small molecules docked into the engineered FKBP12 F36V cavity of 1BL4 (1.9 Å), each supplied as a complete protein–ligand complex.
Molecules were generated by the Technetium TC-43.ai engine (GA-II generation).
Target setup, receptor validation and dataset curation by Claude Code.
Target
FKBP12 (P62942) is a 12 kDa peptidyl-prolyl isomerase and the receptor for FK506 and rapamycin. The F36V mutation enlarges the ligand cavity, creating a "hole" that accepts correspondingly "bumped" synthetic ligands while wild-type FKBP12 does not — the basis of the bump-hole systems used throughout chemically induced proximity, including dTAG degron tagging and heterobifunctional proximity-inducing molecules.
PDB 1BL4 is FKBP mutant F36V complexed with a remodeled synthetic ligand — the reference bumped ligand AP1497 (693.8 Da). The receptor here is the deposited dimer: chains A and B, 107 residues each (mature FKBP12, initiator Met removed, so the mutation sits literally at position 36 and receptor numbering is UniProt − 1). AP1497 is retained in the chain B cavity; the designs occupy the chain A cavity.
Binding site
All 165 designs bind the chain A FKBP cavity. Contact frequencies across the set:
| residue | % of poses | residue | % of poses | |
|---|---|---|---|---|
| Trp59 | 100% | Asp37 | 77% | |
| Tyr82 | 100% | Val36 | 70% | |
| Ile56 | 100% | Glu54 | 60% | |
| Val55 | 100% | Phe99 | 47% | |
| Tyr26 | 98% | Ile91 | 27% | |
| Ile90 | 95% | Gln53 | 15% | |
| Phe46 | 87% | Gly28 | 15% |
Trp59, Tyr82, Ile56 and Val55 form the invariant floor of the cavity — every pose touches all four.
Val36 engagement — read this before selecting compounds
Val36 is the mutation. It is the only residue that distinguishes this receptor from wild-type FKBP12, so a design that does not contact it has no structural basis for preferring F36V over wild type. Wild-type FKBP12 is one of the most abundant cytosolic proteins in mammalian cells, which makes that distinction the difference between a usable chemical-biology tool and one swamped by the endogenous pool.
val36_contact = True— 115 of 165 designs (70%). Use this subset where F36V discrimination matters.- The remaining 50 bind the conserved cavity floor only and should be treated as generic FKBP12 binders.
This dataset does not include wild-type FKBP12 counter-docking; Val36 contact is a structural proxy, not a measured selectivity.
Contents
| file | description |
|---|---|
designs.csv |
one row per design — 29 columns |
ligands.sdf |
all 165 poses, bond orders and formal charges assigned from the SMILES template |
receptor_1BL4_FKBP12_F36V.pdb |
chains A + B plus the AP1497 reference ligand |
structures/ |
165 complete protein–ligand complexes |
Columns
design_id, rank, smiles, pose_smiles, stereo_check, vina_score,
ligand_efficiency, mw, clogp, tpsa, qed, hbd, hba, rotatable_bonds,
heavy_atoms, rings, aromatic_rings, fsp3, formal_charge, murcko_scaffold,
chemotype_cluster, n_contact_residues, contact_residues, val36_contact,
min_dist_protein_ang, min_dist_ap1497_ang, steric_clash,
ecfp4_similarity_to_ap1497, pose_file
Set characteristics
| designs (mean) | AP1497 reference | |
|---|---|---|
| Vina score | −10.56 (best −12.30) | — |
| ligand efficiency | 0.34 | — |
| molecular weight | 433 | 694 |
| heavy atoms | 31 | 50 |
| cLogP | 3.17 | 5.99 |
| TPSA | 87.6 | 139.3 |
| rotatable bonds | 6.3 | 17 |
| QED | 0.44 | 0.17 |
All 165 SMILES are unique, spanning 142 Murcko scaffolds and 66 chemotypes (Butina on ECFP4 at Tanimoto 0.4), with 46 singletons and a largest cluster of 33.
The designs are chemically independent of the reference. Maximum ECFP4 similarity to AP1497 across the set is 0.19 (mean 0.13), and none of the 165 contains a pipecolate ester — the canonical FKBP-binding motif shared by FK506, rapamycin, SLF and AP1497. The set explores the cavity with different chemistry rather than re-deriving the known pharmacophore. Whether that is an advantage or a liability depends on how much the pipecolate anchor contributes to the binding you need.
Pose quality
Docking was rigid-receptor with a fixed receptor across the whole set (verified: a single set of receptor and AP1497 coordinates in all 165 files). Poses are sterically clean:
- closest heavy-atom contact to protein: median 2.97 Å (5th–95th percentile 2.67–3.11)
- only 3 of 165 poses have any atom within 2.5 Å of the protein (
steric_clash) - zero poses clash with AP1497 in the adjacent chain B cavity
- all 165 ligands round-tripped 3D pose → bond orders → SMILES with matching connectivity
Scores were pre-filtered upstream at −10.0 kcal/mol, so the set contains nothing above that value and the distribution describes the surviving tail only. Treat scores as a ranking signal, not affinity.
Citation
Molecules generated by the Technetium TC-43.ai engine. Receptor validation and dataset
curation by Claude Code. Released under CC-BY-4.0.